WSA
VRTX icon

Wall Street Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Wall Street Associates’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,260
Closed -$650K – 345
2015
Q2 		$650K Sell
5,260
-300
-5% -$37.8K 0.06% 249
2015
Q1 		$656K Hold
5,560
– – 0.06% 249
2014
Q4 		$661K Hold
5,560
– – 0.06% 231
2014
Q3 		$624K Buy
5,560
+853
+18% +$81.2K 0.06% 233
2014
Q2 		$446K Sell
4,707
-820
-15% -$57.5K 0.04% 269
2014
Q1 		$391K Hold
5,527
– – 0.03% 284
2013
Q4 		$411K Sell
5,527
-60
-1% -$4.18K 0.03% 283
2013
Q3 		$424K Sell
5,587
-4,887
-47% -$389K 0.04% 271
2013
Q2 		$839K Buy
+10,474
New +$771K 0.09% 200

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return